Skip to main content
HYDROGEN STUDIESPOWERED BY ECHO WATER

Electrolyzed-Reduced Water and Amyloid Beta in Lab Tests

Electrolyzed-reduced water mitigates amyloid beta toxicity via DAF-16 in C. elegans

Research hubs: Brain & Nervous System

This research was done on cells or tissue in a lab, not in people or animals.

Scientific visualization of hydrogen therapy research for Electrolyzed-reduced water mitigates amyloid beta toxicity via DAF-16 in C. elegans
Evidence type
Laboratory study (cells or tissue)
Authors
Jin-Sun Lee, Seul-Ki Park, Sang-Kyu Park
Journal
Toxicology and Environmental Health Sciences
Year
2016
Study Type
Nematode (Caenorhabditis elegans)
Delivery
Water (Electrolysis)
Outcome
Positive
Peer Reviewed
Yes
Cited by
1 (OpenAlex, as of November 2026)
Country
South Korea

TL;DR

A special type of water created through electrolysis, called electrolyzed-reduced water, may help delay the damaging effects of Alzheimer's disease in worms.

Key Finding

Electrolyzed-reduced water delayed amyloid beta-induced paralysis and age-related movement decline in worms through a cellular mechanism involving the DAF-16 protein.

Summary

Researchers tested electrolyzed-reduced water (water treated with electricity to add antioxidants) on tiny worms genetically engineered to produce amyloid beta, a protein linked to Alzheimer's disease. Worms drinking this water showed slower paralysis and better movement as they aged compared to control worms. The protective effect appeared to work through a specific cellular pathway involving a protein called DAF-16.

Practical Takeaway

This is an early-stage study in worms only, not humans, so it cannot yet support any health claims about hydrogen water and Alzheimer's disease. The findings suggest electrolyzed-reduced water may have antioxidant effects worth studying further, but human research would be needed to determine if similar benefits occur in people.

Abstract (excerpt)

Alzheimer’s disease is an age-related neurodegenerative disease. Extracellular aggregation of amyloid beta is a well-known hallmark of Alzheimer’s disease and believed to be critical for the development of Alzheimer’s disease. Lots of efforts have been put on finding an intervention alleviating…

Read the full abstract via DOI